Therefore, we developed a multi-biomarker model based on TEX-related genes that can help physicians assess the prognosis and tumor microenvironment of HCC patients and provide a theoretical basis for individualized and precise treatment. The gene discussed is TEX46; the disease is hepatocellular carcinoma.